Effect and Safety of Calorie Restriction and Complex Herbal Medicine Short-term Treatment ('Oil-rescue' Program) for Weight Reduction of Obesity or Overweight Patients: A Practice Based Research

과체중 및 비만 환자의 체중감량을 위한 식사량 조절 및 복합 한약 단기 치료(5일 레스큐 프로그램)의 효과와 안전성: 진료기반 연구

  • Received : 2020.10.14
  • Accepted : 2020.12.04
  • Published : 2020.12.30


Objectives: This study is a practice based research conducted to investigate the effectiveness and safety of a 5-day short-term diet program ('Oil-rescue' program) designed to reduce the adverse events and initial dropout rate in obesity treatment. Methods: We retrospectively analyzed 4 Korean medicine clinic patient data who completed 'Oil-rescue' program which is consisting of Gambi-hwan, Bium-hwan, Butgiban-hwan and Jayoon Kyungokgo. The weight change before and after participating 'Oil-rescue' program was primary outcome of our study. Changes in body mass index, body fat mass, skeletal muscle mass, body water content, lean body mass, protein, and minerals were also measured. Results: A total of 35 patients who satisfied the eligible criteria were finally included. The body weight decreased from 69.45±11.86 kg to 67.43±11.58 kg, a total of 2.02±1.03 kg (P<0.001). Body fat mass decreased from 25.77±7.45 kg to 24.98±7.26 kg, a total of 0.78±1.21 kg (P<0.001). Body mass index decreased from 26.39±3.64 kg/㎡ to 25.64±3.49 kg/㎡, a total of 0.75±0.41 kg/㎡. (P<0.001). A total of 15 patients had side effects such as diarrhea, abdominal pain, and insomnia, but all were mild. 16 out of 35 people switched to long-term obesity treatment programs. Conclusions: Through this retrospective practice based research, it was found that the 'Oil-rescue' program effectively reduced body weight, body fat, and body mass index, and the other obesity related parameters. It was a relatively safe and effective short-term obesity treatment program.



  1. Jeong JW, Cho SW. Trend research of the human body-oriented obesity studies on Korean medicine. J Korean Med Rehabil. 2016 ; 26(1) : 49-61.
  2. Korea Health Statistics 2018: Korea National Health and Nutrition Examination Survey (KNHANES VII-3) Cheongju : Division of Health and Nutrition Survey, Center for Disease Control and Prevention, KCDC. 2019.
  3. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Meta bolism. 2019 ; 92 : 6-10.
  4. Kinlen D, Cody D, O'Shea D. Complications of obesity. QJM Int J Med. 2018 ; 111(7) : 437-43.
  5. Chun J, Han HW, Kim J, Yoon S. Digital health care programs for obesity management in South Korea: a systematic review. Korea Open Access J. 2020 ; 40(1) : 560-91.
  6. Cho SH, Kim KK. Obesity treatment in ambulatory care focused on pharmacotherapy. Korean J Fam Pract. 2020 ; 10(2) : 77-86.
  7. Kim MK, Kim CS. Recent advances in anti-obesity agents. Korean J Med. 2018 ; 93(6) : 501-8.
  8. Han K, Lee MJ, Kim H. Systematic review on herbal treatment for obesity in adults. J Korean Med Rehabil. 2016 ; 26(4) : 23-35.
  9. Shin WY, Seo GS, Song JH, Baek CH. The retrospective analysis on obese and overweight female patients with Korean medical treatment and its effectiveness for clinical setting of seasonal treatment. J Korean Med Obes Res. 2017 ; 17(1) : 10-9.
  10. Song YK, Lim HH. Clinical application of Ma Huang in the obesity treatment. J Soc Korean Med Obes Res. 2007 ; 7(1) : 1-7.
  11. Astrup A, Breum L, Toubro S, Hein P, Quaade F. Ephedrine and weight loss. Int J Obes Relat Metab Disord J Int Assoc Study Obes. 1992 ; 16(9) : 715.
  12. Jo SI, Lee JK, Shin JY. Factors related to failure in weight reduction or maintenance in Korean adults. Korean J Fam Pract. 2017 ; 7(1) : 72-9.
  13. Lee CJ, Kim MJ, An SJ. Current treatments on obesity. Korean J Health Promot. 2019 ; 19(4) : 171.
  14. Stotland SC, Larocque M. Early treatment response as a predictor of ongoing weight loss in obesity treatment. Br J Health Psychol. 2005 ; 10(4) : 601-14.
  15. Jo GW, Ok JM, Kim SY, Lim YW. Review on the efficacy and safety of Mahuang and ephedrine in the treatment of obesity -focused on RCT-. J Korean Med. 2017 ; 38(3) : 170-84.
  16. National Cancer Institute. Grading: General Characteristics of the CTCAE (Common Terminology Criteria for Adverse Events) Grading (Severity) Scale. 2012. Available from:
  17. World Health Organization (WHO)-Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment. 2012. Available from:
  18. Yoon SH, Lee EJ, Jo HJ, Han YJ, Kim HH, Yun YH, et al. Effect and safety of combined treatment of Gambihwan and Garcinia Cambogia on weight loss: a retrospective observational study. J Korean Med Obes Res. 2020 ; 20(1) : 31-9.
  19. Lee E, Yoon SH, Kim H, Kim YD, Leem J, Park J. Ephedrae Herba in combination with herbal medicine (Zhizichi decoction and Phellodendri Cortex) for weight reduction: a case series. Integr Med Res. 2020 ; 9(2) : 100408.
  20. Song MY, Kim HJ, Lee MJ. The safety guidelines for use of Ma-huang in obesity treatment. J Korean Med Obes Res. 2006 ; 6(2) : 17-27.
  21. Jo DH, Lee S, Lee JD. Effects of Gambisan in overweight adults and adults with obesity: a retrospective chart review. Medicine (Baltimore). 2019 ; 98(47) : e18060.
  22. Kim SY, Park YJ, Park YB. Review on predictors of dropout and weight loss maintenance in weight loss interventions. J Korean Med. 2016 ; 37(3) : 62-73.
  23. Yoon NR, Yoo YJ, Kim MJ, Kim SY, Lim YW, Lim HH, et al. Analysis of adverse events in weight loss program in combination with 'Gamitaeeumjowee-Tang' and low-calorie diet. J Korean Med Obes Res. 2018 ; 18(1) : 1-9.
  24. Yun YJ, Shin BC, Lee MS, Cho SI, Park JH, Lee HJ. Systematic review of the cause of drug-induced liver injuries in Korean literature. J Korean Orient Med. 2009 ; 30(2) : 30-45.

Cited by

  1. 조위승청탕(調胃升淸湯)의 비만 및 대사성 질환에 대한 연구동향 분석: 국내 학술지를 중심으로 vol.31, pp.4, 2020,